Polyphor stays above water after Sfr165m IPO

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

Polyphor stays above water after Sfr165m IPO

Aidan Gregory
May 15, 2018 02:00 pm
Swiss_francs_fotolia_230x150
One Swiss Franc coin on fluctuating graph. Rate of the Swiss Franc (shallow DOF) | VALERIYA POTAPOVA/Valerie Potapova - stock.adobe.com

Swiss biopharmaceutical company Polyphor has bucked the trend of recent European IPOs by pricing its IPO at Sfr38, in the top half of the initial Sfr30 to Sfr40 range, and increasing the size of the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

SwitzerlandDeutsche BankEquity IPOsUBSEquityEuropeEMEASRI
AG
Aidan Gregory
Gift this article